CLASS I Device recall · Reported 29 Jan 2014 · FDA Enforcement Report

Trufill¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System recalled

Codman & Shurtleff is recalling Trufill¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System, distributed nationwide in the US. The recall was initiated on 11 Oct 2013 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesAll lot codes
Quantity recalled3,860

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0788-2014
FDA event ID
66493
Recalling firm
Codman & Shurtleff, Raynham, MA
Classification
Class I
Status
Terminated
Recall initiated
11 Oct 2013
FDA classified
23 Jan 2014
Reported
29 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

11 Oct 2013Recall initiated by company
23 Jan 2014Classified by FDA+104 days
29 Jan 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Incorrect instructions for use (IFU).

Product as listed by the FDA

TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System; Two 1 g tubes of n-BCA, one 10 mL vial of Ethiodized Oil and one 1 g vial of Tantalum Powder Product Code: 631-400; The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired.

Where it was distributed

Worldwide Distribution: US (nationwide) including Puerto Rico; and internationally to: Costa Rica and Russia.

Nationwide Puerto Rico

Questions about this recall

Is Trufill¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System recalled?

Yes. Codman & Shurtleff recalled Trufill¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System on 11 Oct 2013. The recall is Class I and its status is Terminated. Recall number Z-0788-2014.

Why was it recalled?

Incorrect instructions for use (IFU).

Which lots are affected?

All lot codes

Where was it sold?

Worldwide Distribution: US (nationwide) including Puerto Rico; and internationally to: Costa Rica and Russia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Codman & Shurtleff

All 59

Other Heart & Vascular Devices recalls

All 6,190